Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-16-009187
Filing Date
2016-12-23
Accepted
2016-12-23 16:15:34
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROTALIX BIOTHERAPEUTICS, INC. p16-2349sc13g.htm SC 13G 48114
  Complete submission text file 0000902664-16-009187.txt   50053
Mailing Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019
Business Address 40 WEST 57TH ST. 32ND FLOOR NEW YORK NY 10019 2122874900
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) CIK: 0000919185 (see all company filings)

EIN.: 134131516 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 162069132
SIC: 2836 Biological Products, (No Diagnostic Substances)